+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
BERLDRG BERLDRG

Beryl Drugs Share Price

₹24.00 -1.6 (-6.25%)
50.75% Gain from 52W Low

02 Nov, 2026 4:01 PM (IST)

Beryl Drugs live price: ₹24.00. It opened at ₹23 vs previous close ₹26; intraday high/low: ₹25/₹23. The 50 & 200 DMA stand at ₹24.20/₹23.20.

Beryl Drugs Performance

  • Today's Low
  • ₹23
  • Today's High
  • ₹25
  • 52 Week Low
  • ₹16
  • 52 Week High
  • ₹28
  • Open Price₹23
  • Previous Close₹26
  • Volume1,545
  • 50 DMA₹24.20
  • 100 DMA₹23.60
  • 200 DMA₹23.20

Beryl Drugs Chart

Investment Returns

  • Over 1 Month -5.1%
  • Over 3 Month + 18.52%
  • Over 6 Month + 10.09%
  • Over 1 Year -0.12%

Smart Investing Starts Here Start SIP with Beryl Drugs for Steady Growth!

Invest Now

Beryl Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 19.5
  • PEG Ratio
  • 0.1
  • Market Cap Cr
  • 12
  • P/B Ratio
  • 1.2
  • Average True Range
  • 2.7
  • EPS
  • 1.2
  • Dividend Yield
  • 0
  • MACD Signal
  • 0.1
  • RSI
  • 45.78
  • MFI
  • 30.59

Latest Stock News Updates

Beryl Drugs Ltd - 524606 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

CERTIFICATE UNDER REGULATION 74(5) OF SEBI (DP) REGULATIONS, 2018 FOR THE QUARTER ENDED 30.09.2026

Beryl Drugs Ltd - 524606 - Compliance-57 (5) : intimation after the end of quarter

NON- APPLICABILITY CERTIFICATE UNDER REGULATION 57(5) FOR THE QUARTER ENDED 30.09.2026

Beryl Drugs Ltd - 524606 - Closure of Trading Window

CLOSURE OF TRADING WINDOW

Beryl Drugs Financials

Beryl Drugs Technicals

EMA & SMA

Current Price
₹24.00
-1.6 (-6.25%)
pointer
  • Bearish Moving Average 11
  • Bullish Moving Average 5
  • 20 Day
  • ₹24.70
  • 50 Day
  • ₹24.20
  • 100 Day
  • ₹23.60
  • 200 Day
  • ₹23.20

Resistance and Support

24.17 Pivot Speed
  • R3 27.00
  • R2 26.20
  • R1 24.90
  • S1 22.70
  • S2 21.90
  • S3 20.60

Beryl Drugs Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-09-02 A.G.M.
2026-08-11 Quarterly Results
2026-06-16 Others Inter alia, to consider and approve change in registered office of the company within local limits of the same city.
2026-05-28 Audited Results
2026-04-01 Notice of EGM & Others Inter-alia, to consider 1. Appointment of Mr. Shailendra Pathak as the Whole Time Director. 2. Appointment of Abhay Bhandari & Associates. 3. Authorize Directors of the Com. 4.Other business matters.

Beryl Drugs Shareholding Pattern

72.03%
27.97%
0%

Beryl Drugs FAQs

Beryl Drugs share price is ₹24 As on 02 November, 2026 | 17:50

The Market Cap of Beryl Drugs is ₹12.2 Cr As on 02 November, 2026 | 17:50

The P/E ratio of Beryl Drugs is 19.5 As on 02 November, 2026 | 17:50

The PB ratio of Beryl Drugs is 1.2 As on 02 November, 2026 | 17:50

The 52 week High & Low of Beryl Drugs is ₹27.9/₹15.9 respectively As on 02 November, 2026 | 17:50

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23